Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002YC7
CNY
10.82
-0.17 (-1.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
226.71
181.89
190.36
160.66
198.91
150.10
210.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
226.71
181.89
190.36
160.66
198.91
150.10
210.09
Raw Material Cost
85.05
74.33
74.35
71.53
78.89
61.59
86.58
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.31
1.32
2.29
2.14
3.27
3.39
3.74
Selling and Distribution Expenses
59.52
53.85
70.52
52.81
68.80
49.81
60.02
Other Expenses
1.04
0.61
0.73
1.16
0.71
0.75
0.73
Total Expenditure (Excl Depreciation)
156.28
135.58
154.42
138.09
158.01
122.31
157.67
Operating Profit (PBDIT) excl Other Income
70.4
46.3
35.9
22.599999999999998
40.9
27.799999999999997
52.400000000000006
Other Income
1.15
1.06
66.63
10.25
4.51
4.49
8.54
Operating Profit (PBDIT)
90.66
68.92
102.89
58.38
67.35
54.61
69.67
Interest
1.31
1.32
2.29
2.14
3.27
3.39
3.74
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
141.66
107.56
116.01
89.14
120.02
88.51
123.51
Depreciation
23.77
23.77
24.42
24.42
23.95
23.95
19.42
Profit Before Tax
65.58
43.84
76.18
31.82
40.13
27.27
46.51
Tax
9.05
6.47
4.07
2.45
5.91
4.93
6.46
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
66.63
45.79
83.63
40.61
43.78
32.68
48.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
66.63
45.79
83.63
40.61
43.78
32.68
48.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.44
1.08
0.15
-0.11
0.01
0.05
-0.40
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
67.07
46.87
83.78
40.49
43.79
32.73
48.55
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,283.95
1,298.02
1,260.08
1,243.95
1,203.34
1,225.01
1,192.31
Earnings per share (EPS)
0.21
0.14
0.26
0.12
0.13
0.1
0.15
Diluted Earnings per share
0.21
0.14
0.26
0.12
0.13
0.1
0.15
Operating Profit Margin (Excl OI)
29.0%
24.24%
6.22%
14.76%
19.55%
17.43%
19.85%
Gross Profit Margin
39.41%
37.17%
52.85%
35.01%
32.21%
34.12%
31.38%
PAT Margin
29.39%
25.18%
43.93%
25.28%
22.01%
21.78%
23.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 24.63% vs -4.46% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 43.07% vs -44.03% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 31.81% vs 87.05% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -43.48% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
226.71
0
226.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
226.71
0
226.71
Raw Material Cost
85.05
0
85.05
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.31
0
1.31
Selling and Distribution Expenses
59.52
0
59.52
Other Expenses
1.04
0.00
1.04
Total Expenditure (Excl Depreciation)
156.28
0
156.28
Operating Profit (PBDIT) excl Other Income
70.43
0.00
70.43
Other Income
1.15
0
1.15
Operating Profit (PBDIT)
90.66
0
90.66
Interest
1.31
0
1.31
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
141.66
0
141.66
Depreciation
23.77
0
23.77
Profit Before Tax
65.58
0
65.58
Tax
9.05
0
9.05
Provisions and contingencies
0
0
0.00
Profit After Tax
66.63
0
66.63
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
66.63
0
66.63
Share in Profit of Associates
0
0
0.00
Minority Interest
0.44
0
0.44
Other related items
0.00
0.00
0.00
Consolidated Net Profit
67.07
0
67.07
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,283.95
0
1,283.95
Earnings per share (EPS)
0.21
0
0.21
Diluted Earnings per share
0.21
0
0.21
Operating Profit Margin (Excl OI)
29.00%
0%
0.00
29.00%
Gross Profit Margin
39.41%
0%
0.00
39.41%
PAT Margin
29.39%
0%
0.00
29.39%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 22.67 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 24.63% vs -4.46% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 13.98% vs 16.93% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.71 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 43.07% vs -44.03% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 53.20% vs -13.61% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.95 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 31.81% vs 87.05% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 42.52% vs 27.13% in Jun 2024

Quarterly - Interest
Interest 0.13 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -43.48% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -60.61% vs -19.51% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.00%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024